BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180313
DTEND;VALUE=DATE:20180315
DTSTAMP:20260515T042510
CREATED:20171213T031929Z
LAST-MODIFIED:20171213T031929Z
UID:5302-1520899200-1521071999@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials Southeast
DESCRIPTION:For the 7th Outsourcing in Clinical Trials conference we will once again be welcoming a number of senior industry peers who given their experience will present\, debate and drive the conversation over our two day event. In 2018 you will be given the opportunity to delve straight into the big hot topics facing your outsourcing and operational challenges with regards to clinical trials and be prepared to address the changes facing the industry\, ensuing you are fully equipped for the future. \nSome hot topics highlights which we will be addressing at next year’s event are: \n– Uncovering ways through which you can manage your vendors without duplicating tasks\, affecting trial integrity and increasing in-house responsibilities \n– Improving staff recruitment; discussing how industry and academia can work together to ensure adequate training for future clinical trial staff to ensure trials are not compromised \n– To outsource or not to outsource\, this is the question? Examining the arguments behind keeping capabilities in house versus contracting out \n– Approaching funding opportunities strategically; which funding options are available for small-midsize pharma and biotech to boost your pipeline \nThese sessions will endeavour not only to answer questions\, but to open the floor to discussion so that sponsors and vendors alike can interact with one another and discover ways through which relationships and expectations can be best managed. With panel discussions\, debates and presentations\, this year’s program is certain to provide a platform for each and every delegate to explore the challenges affecting them and what feasible solutions could be adopted to solve these.
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-southeast/
LOCATION:Durham\, North Carolina
ORGANIZER;CN="Arena International":MAILTO:Events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180312
DTEND;VALUE=DATE:20180314
DTSTAMP:20260515T042510
CREATED:20171106T102949Z
LAST-MODIFIED:20171107T021556Z
UID:3811-1520812800-1520985599@www.pharmajournalist.com
SUMMARY:2nd Digital Pharma Multichannel Marketing Boot Camp West
DESCRIPTION:The 2nd Digital Pharma Multichannel Marketing Boot Camp West uses a combination of lectures\, class discussions and hands-on exercises with people who want to understand how to create effective and sophisticated digital and multichannel marketing (MCM) strategies. This intensive\, two-day program not only teaches you strategic processes\, it also gives you the tools and skills you need to gather insights and develop your own digital and multichannel programs. \nTo learn more about this event\, and to register online\, visit http://digitalpharmaseries.com/bootcamp \n 
URL:https://www.pharmajournalist.com/event/2nd-digital-pharma-multichannel-marketing-boot-camp-west/
LOCATION:Hilton San Francisco Airport Bayfront\, 600 Airport Boulevard\, Burlingame\, CA\, 94010\, United States
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180307
DTEND;VALUE=DATE:20180309
DTSTAMP:20260515T042510
CREATED:20171212T070945Z
LAST-MODIFIED:20171212T070945Z
UID:5264-1520380800-1520553599@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply New England
DESCRIPTION:The 7th Annual Clinical Trial Supply New England is back in 2018 on the 7th-8th March for what promises to be a fantastic event. The perfect event for all biotech’s and pharma companies in the New England region to come together and explore the latest issues\, trends and technologies within the clinical supply world. \nUnderstanding the characteristics of the region\, we have created a two days conference with full of sessions that will be an interest of smaller pharma and biotechs. It is all geared up with fresh up-to-date topics that you can learn from how your peers in the industry are managing the challenges and seek for new strategies from thought-provoking discussions. \nHere is the preview of two key topics for the 2017 event. \nImport and export regulation \nNo one likes getting unexpected bills. So do you. Marco Afonso\, Supervisory Import Specialist at U.S. Customs and Border Protection will be presenting a detailed exploration the evolving landscape of importing clinical trial materials and products into the US specifically investigating the key facts all companies should know when importing to the US to clarify your obligations to tax\, VAT and regulatory transgressions. \nContingency planning for natural disasters \nAs climate change worsens and typical weather patterns are altered resulting in unforeseen natural phenomena it is paramount of the industry to be able to react in a quick\, seamless manager when typical supply chain routes are disrupted. Chad Presher\, Associate Director\, Clinical Drug Supply\, Biogen will be presenting a case study which will among other things\, focus on the implications of hurricane Harvey on clinical trials to better prepare responses to ensure trial supply reaches the site
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-new-england/
LOCATION:Boston\, MA
ORGANIZER;CN="Arena International":MAILTO:Events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180221
DTEND;VALUE=DATE:20180223
DTSTAMP:20260515T042510
CREATED:20171023T075622Z
LAST-MODIFIED:20171023T084319Z
UID:3564-1519171200-1519343999@www.pharmajournalist.com
SUMMARY:3D Cell Culture 2018
DESCRIPTION:Building on the sell-out success of the launch event\, SMi Group is delighted to announce the return of 3D Cell Culture\, taking place on 21st and 22nd of February 2018\, in London UK. \n3D Cell Culture is rapidly growing with incredible potential for industrial application and a widespread reach that can be seen across many different fields\, such as 3D bioprinting and microfluidics. \nThe 2nd annual conference will explore these overlapping areas and will combine pioneering breakthroughs with scientific research to strengthen your commercial success. Join us for exclusive insight into key topics such as disease models\, organoids\, organ-on-a-chip technologies\, iPSC advances plus much more!  \nFEATURED SPEAKERS: \n– Gary Allenby\, Business Development Director and Chief Scientific Officer\, Aurelia Bioscience\n– Mr Stefan Przyborski\, Scientific Founder\, ReInnervate Limited\n– Mr Ricardo Baptista\, Lead Scientist Process Development\, Cell and Gene Therapy Catapult\n– Dr Nicholas Leslie\, Tumour Biologist\, Heriot-Watt University\n– Dr SuwanJaysinghe\, Professor of Bioengineering\, University College London\n– Dr Max Salick\, Postdoctoral Researcher\, Novartis Institutes for Biomedical Research\n– Dr Patrick Kugelmeier\, Director of Science\, Kugelmeiers\n– Dr Vitor Santo\, Senior Scientist\, Immunocore\n– Mr Christopher Schofield\, Investigator\, GSK\n– Mr David Pan\, Programme Manager (Regenerative Medicine)\, UK Regenerative Medicine Platform\n– Dr Reyk Horland\, Head of Business Development\, TissUse GmbH \nREASONS TO ATTEND IN 2018\n \n– Uncover the biology of human neurodevelopment diseases in 3D by merging cutting edge technologies in CRISPR editing and single cell sequencing\n– Take a 3D biology approach to overcome challenges for well based screening with exclusive insight into electrospun micro-scaffold based biology\n– Develop strategies for optimising placement of cells in printing by identifying key developments in the overlap of 3D bioprinting and 3D cell culturing\n– Discover new approaches to predictive substance testing through innovative case study insight into multi-organ-chip technology\n– Benefit from an agenda tailored towards driving clinical development through ground breaking case studies on the Zika virus and tuberous sclerosis \n2017 ATTENDEE TESTIMONIALS \n“Very good presentations and a few outstanding ones… I made some useful contacts” ASTERAND BIOSCIENCE \n“The conference was wonderfully organised” NOVARTIS \n“Good start\, love to see the event occur again” THERMO FISHER SCIENTIFIC \n\nFor further details visit http://www.3D-CellCulture.com/pjournalist or contact the team on +44 (0)20 7827 6000
URL:https://www.pharmajournalist.com/event/3d-cell-culture-2018/
LOCATION:Holiday Inn Kensington Forum\, London UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:events@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180221
DTEND;VALUE=DATE:20180223
DTSTAMP:20260515T042510
CREATED:20171011T060348Z
LAST-MODIFIED:20171011T060745Z
UID:3391-1519171200-1519343999@www.pharmajournalist.com
SUMMARY:10th Annual Pharma Packaging and Labeling East Coast Conference
DESCRIPTION:The 10th Annual Pharma Packaging and Labeling East Coast event aims to create an environment where commercial packaging and labeling teams work together to successfully manage both creative and regulatory demands while safeguarding products and protecting patients. To achieve this we have brought together top industry leaders whose experience will enable you to make this a reality. \nThis year we will be exploring topics which affect both commercial labelling and packaging teams across small\, medium and large pharma. We will have a co-presentation looking at the industries end-to-end labeling strategy to ensure companies are inspection ready while harnessing branding as a story telling the tool to remain relevant to your consumers\, old and new. Coupled with this we aim to show ways through which the operational challenges of serialization can be overcome and improved to ensure you are meeting compliance standards. We are also happy to announce that the Drug Enforcement Administration will be returning\, offering an opportunity to hear a different perspective on ways that pharma can serve the public health. \nTo learn more about this event\, and to register online\, visit https://goo.gl/3HhKjN
URL:https://www.pharmajournalist.com/event/10th-annual-pharma-packaging-labeling-east-coast-conference/
LOCATION:Philadelphia\, USA\, TBA
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180206
DTEND;VALUE=DATE:20180208
DTSTAMP:20260515T042510
CREATED:20171031T005520Z
LAST-MODIFIED:20171031T005651Z
UID:3633-1517875200-1518047999@www.pharmajournalist.com
SUMMARY:12th annual Parallel Trade
DESCRIPTION:SMi Group is proud to announce the return of Europe’s only Parallel Trade conference. Back for the 12th year\, Parallel Trade returns to London on 6th-7th February 2018. \n \nOver the years\, the European Single market has allowed for pharmaceuticals to be imported and exported freely between member states without the permission of the manufacturers. However\, with the arrival of Brexit and guidelines to immanently enforce the Falsified Medicines Directive (FMD) by 2019\, the market for pharmaceutical parallel trade is changing. \nJoin us as we discuss the latest changes to regulation\, their implementation and major court cases in intellectual property influencing distribution practices. We will also be exploring the safety of patients in relation to the surge in pharmaceutical E-commerce and ways in which currency fluctuations are likely to disrupt the flow of drugs to certain countries in the EU and beyond. \nWith huge interest from leaders in the field\, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Parallel Trade event. This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers \nParallel Trade 2018 will cover the important issues of:\n \n– Maintaining the integrity of the supply chain\n– Addressing recent developments concerning intellectual property and regulatory law\n– Forecasting currency fluctuations across the single market and the affect this might have on drug shortages\, prices and patient accessibility\n– Exploring how Brexit will impact pharmaceutical trade and\n– market access in Europe\n– Providing an insight into current anti-trust investigations from industry leaders and the consequences this could have on pharmaceutical parallel trade
URL:https://www.pharmajournalist.com/event/12th-annual-parallel-trade/
LOCATION:Holiday Inn Kensington Forum\, London UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:kwilliams@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180205
DTEND;VALUE=DATE:20180208
DTSTAMP:20260515T042510
CREATED:20171121T064101Z
LAST-MODIFIED:20171121T064454Z
UID:4351-1517788800-1518047999@www.pharmajournalist.com
SUMMARY:3rd annual North American Microbiome Congress
DESCRIPTION:The 3rd Annual North America Microbiome Congress in San Diego\, by Kisaco Research\, has become a trusted learning and networking platform and a true business community for microbiologists\, clinicians regulatory and industry executives who require an insight into the latest microbiome research\, clinical trials and collaborative partnerships. \nWith a focus on 5 microbiome niches such as the gut\, lung\, oral\, skin and vaginal- we invite you to join us for 3 days of intense learning\, mind-sharing and networking opportunities designed to encourage meaningful connections. In addition\, we will be hosting poster sessions for PhD students to provide opportunities for all scientists to learn about state-of-the-art research methods and clinical protocols for conducting microbiome work. \n– Meet and learn from industry leaders\n– Consider the practical aspects of promoting effective partnerships\n– Learn from the latest unpublished data\n– Network with top academics and clinicians in the field
URL:https://www.pharmajournalist.com/event/3rd-annual-north-american-microbiome-congress/
LOCATION:The Hilton San Diego Resort & Spa\, 1775 East Mission Bay Drive\, San Diego\, CA\, 92109\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180130
DTEND;VALUE=DATE:20180201
DTSTAMP:20260515T042510
CREATED:20171013T002500Z
LAST-MODIFIED:20171013T003516Z
UID:3441-1517270400-1517443199@www.pharmajournalist.com
SUMMARY:LEAP HR: Life Sciences: West Coast Edition
DESCRIPTION:Step Inside the Innovative People Strategies Helping the Most Dynamic Life Sciences Firms Break Through in a Hyper-Competitive Industry \nThis West Coast edition of LEAP HR: Life Sciences offers you the chance to step inside the people strategies helping the most innovative biopharma businesses build a scalable culture of innovation during rapid growth. \nIt shines a light on how you can transform HR impact in a fast-moving industry\, manage the people implications of growth\, and rethink engagement\, retention and rewards in a hyper-competitive industry. \nThis is a high-energy\, high impact\, fully-immersive experience. It’s the place for ambitious people leaders to engage in a disruptive dialogue around how to deal with the implications of working in a fast-paced\, hyper-competitive\, science-centric industry. Take this opportunity to explore truly transformative strategies to revolutionize HR impact. \nTo learn more about this event\, and to register online\, visit http://bit.ly/leaphrlifesciences
URL:https://www.pharmajournalist.com/event/leap-hr-life-sciences-west-coast-edition/
LOCATION:The Marker 501 Geary Street\, San Francisco\, CA\, 94102\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@leap-hr.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180129
DTEND;VALUE=DATE:20180202
DTSTAMP:20260515T042510
CREATED:20170919T071927Z
LAST-MODIFIED:20170919T073104Z
UID:3147-1517184000-1517529599@www.pharmajournalist.com
SUMMARY:Temperature Controlled Logistics 2018
DESCRIPTION:In planning the 2018 Temperature Controlled Logistics conference\, Pharma IQ surveyed over 50 senior supply chain and logistics experts from big and small pharmaceutical companies\, as well as from consumer industries. The main question they were looking to answer was: what is the main factor that defines a cost effective\, secure\, and GDP compliant temperature controlled supply chain that experiences minimal temperature excursions? The overarching answer was clear: planning. Strengthen your end-to-end supply chain planning\, and your temperature controlled logistics will be easier\, cheaper\, and better. \n  \nIn recognition of this\, TCL 2018\, takes you on a journey from the beginning of your supply chain\, to the very end. The three separate streams will look at: \n-> Pre-Transportation – with sessions such as “Enabling End-to-End Supply Chain Planning\, Visibility\, and Decision Making through Standardisation & IT Integration Across Global Sites” (Merck) and “Optimising Lane Qualification with all Supply Chain Stakeholders in Challenging Shipping Environments” (Bayer) \n-> Transportation – with sessions such as “A Global Approach to Reducing Temperature Excursions” (Genzyme) and “Maintaining Temperature Control in the World’s Most Challenging Situations” (Médecins Sans Frontières) \n-> Last Mile and Post-Distribution – with sessions such as “Last Mile Distribution – The Final Stage of End-to-End Temperature Monitoring (EZR Group) and “Working with Partners to Close Gaps in the Last Mile” (Novartis) \nThe goal of the event  is for each and every delegate who attends TCL 2018 to leave understanding what best practice planning and execution looks like at every stage of their temperature controlled supply chain. With over 50 case studies from pharmaceutical manufactures and regulatory bodies that address key operational and strategic considerations\, bring your team to ensure coverage of all relevant sessions. \nThe  world famous exhibition will\, as per tradition\, run parallel to the conference\, so that you have the chance to identify solution providers who can support the implementation of new solutions and strategies. In a brand new location of Twickenham Stadium\, the big red London bus won’t be joining this year\, but they have plenty of new surprises that await!  Don’t to miss the BRAND NEW Sea Freight Focus Day! Details on the agenda at https://www.temperaturecontrolledlogistics.com/ \nThe early bird special has just kicked off\, and there are a few ways to capitalise on these discounts:\n1. Online here: https://www.temperaturecontrolledlogistics.com/\n2. Email: enquire@iqpc.co.uk\n3. Telephone +44 (0) 20 7036 1300
URL:https://www.pharmajournalist.com/event/temperature-controlled-logistics-2018/
LOCATION:Twickenham Stadium\, London
ORGANIZER;CN="IQPC":MAILTO:enquire@iqpc.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180117
DTEND;VALUE=DATE:20180119
DTSTAMP:20260515T042510
CREATED:20170908T053845Z
LAST-MODIFIED:20170908T054719Z
UID:3027-1516147200-1516319999@www.pharmajournalist.com
SUMMARY:10th Annual Pre-filled Syringes Europe
DESCRIPTION:Join the calendar event highlight for the medical device industry at Europe’s leading 10th annual conference and exhibition on Pre-Filled Syringes when it returns to Central London on 17th and 18th January 2018. Pre-Filled Syringes Europe will once again provide a perfect platform to discuss new advancements and showcase the latest innovations to keep you at the forefront of a dynamic and booming market. \n \nWhat will the future of the pharmaceutical industry look like following an increase in the number of generics and biosimilars hitting the market; a trend in the rise of self-administered drugs and personalised medicine; and Britain’s recent decision to leave Europe? How will these changes affect the PFS industry? \nBuilding on the success of its sell-out global 2017 PFS series of events which saw 100+ attendees join shows in London\, Boston and San Diego\, the agenda for Pre-Filled Syringes Europe 2018 has been carefully tailored to arm you with the key requirements and tools to adapt to an ever-changing medical landscape in areas that are critical to those working within parenteral drug delivery and injectable devices. \nFeatured Speakers: \n– AlphonsFakler\, Group Head Risk Management\, Novartis Pharma\n– BettineBoltres\, Technical Account Manager\, West Pharmaceutical Services\n– Elizabeth Baker\, Group Manager Licensing Division\, MHRA\n– Marcel Mueller\, Device Project Leader\, Novartis\n– Cedric Gysel\, Staff Device Engineer\, Janssen\n– Carsten Worsoe\, Principal Scientist\, CMC Analytical Support\, Novo Nordisk\n– VikasJaitely\, Senior Manager CMC Regulatory Intelligence and Pharmaceutical Science\, Merck\n– Susanne Joerg\, Head of Formulation Development\, Lonza\n– Orla Downes\, Head of Business Development Unit\, Barts Health Pharmaceuticals\n– Barry Knight\, Device Program Lead\, UCB Celltech\n– Sudeshna Dutta Ray\, Senior Engineer\, Advanced Device Technology and Innovation\, Amgen\n– Alexander Jung\, Senior Manager\, Technology and Innovation\, Drug Delivery and Devices\, Boehringer Ingelheim\n– Christian Dechant\, Primary Packaging Director\, Boehringer Ingelheim \nTo learn more about this event\, and to register online\, visit https://goo.gl/xiHQvu  \n 
URL:https://www.pharmajournalist.com/event/10th-annual-pre-filled-syringes-europe/
LOCATION:Copthorne Tara Hotel\, London UK
ORGANIZER;CN="SMI Group Ltd":MAILTO:tarri@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171206
DTEND;VALUE=DATE:20171208
DTSTAMP:20260515T042510
CREATED:20170925T092900Z
LAST-MODIFIED:20170925T092900Z
UID:3237-1512518400-1512691199@www.pharmajournalist.com
SUMMARY:3rd Annual Clinical Trial Supply (CTS) East Asia
DESCRIPTION:This event has now reached its third birthday and is fast becoming an industry must attend show. Since 2015 the event is forecast to almost double in revenue and it’s imperative that the program brings together a mixture of the biggest companies to keep attracting vendors. \nThe delegate campaign has been very successful in both 2015 and 2016\, attracting a large number of attendees from South Korea\, Japan\, China\, Taiwan and Singapore. It’s important that this mix is reflected on the program and that presentations are sought from across East Asia. \n Why CTS East Asia? \nAsia now has more clinical trials than any other region in the world. Through research with suppliers there is some disagreement over whether the local market is growing in terms of companies\, however no dispute at all in the number of trials happening in the region. \nTo learn more about this event\, and to register online\, visit https://goo.gl/UdMMN7
URL:https://www.pharmajournalist.com/event/3rd-annual-clinical-trial-supply-cts-east-asia/
LOCATION:Seoul\, South Korea
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171206
DTEND;VALUE=DATE:20171208
DTSTAMP:20260515T042510
CREATED:20170922T053049Z
LAST-MODIFIED:20170925T092546Z
UID:3194-1512518400-1512691199@www.pharmajournalist.com
SUMMARY:2nd Outsourcing in clinical trials (OCT) East Asia
DESCRIPTION:The aim of the event is to offer case studies and insight into how to effectively outsource and manager clinical trials throughout East Asia. The programme incorporates insight from both small and big pharma and sessions will take place in both English and Korean. \nThis year’s event is taking place in Seoul\, (South Korea) where there is a good balance of local and global pharma companies. Korea has made huge steps towards being recognised as a key player in pharma by specialising in biosimilar \nWhy South Korea? \nThe event is taking place in South Korea\, this is because there is a good balance of local and global pharma companies. Korea also has made huge steps towards being recognised as a key player in pharma by specialising in biosimilar. \nTo learn more about this event\, and to register online\, visit https://goo.gl/cGi5Qy
URL:https://www.pharmajournalist.com/event/2nd-outsourcing-clinical-trials-oct-east-asia/
LOCATION:Seoul\, South Korea
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171205
DTEND;VALUE=DATE:20171207
DTSTAMP:20260515T042510
CREATED:20170829T094533Z
LAST-MODIFIED:20170829T094533Z
UID:2976-1512432000-1512604799@www.pharmajournalist.com
SUMMARY:Clinical Operations in Oncology Trials Europe 2017
DESCRIPTION:The 2016 Clinical Operations in Oncology Trials Europe conference was a thought-provoking two days of engaging presentations from the most innovative oncology companies in the industry. \n \nThe focused\, senior-level audience debated how to improve operational efficiencies in oncology trials to protect product pipeline and rise above the competition.  The 2016 agenda was an exciting mix of panels\, roundtables and case study presentations with representation from leading biopharma companies such as Eli Lilly\, Astrazeneca and Abbvie. \nFollowing on from this success\, Arena International is pleased to announce that this unique event will be returning once again in December 2017. \nThe 2017 program will stay abreast of the latest advances in trial design\, patient recruitment and monitoring in global oncology trials. If you have an interesting topic proposal or case study\, please get in touch with the programme director.
URL:https://www.pharmajournalist.com/event/clinical-operations-oncology-trials-europe-2017/
LOCATION:Munich\, Germany
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171129
DTEND;VALUE=DATE:20171201
DTSTAMP:20260515T042510
CREATED:20170718T041426Z
LAST-MODIFIED:20170718T041608Z
UID:2519-1511913600-1512086399@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Southern California 2017
DESCRIPTION:Clinical Trial Supply Southern California returns for another year to La Jolla\, San Diego. Once again it promises to deliver some of the most cutting edge content in the world of Clinical Trial Supplies.\n \nStandout speakers for 2017 include those from Ionis\, Intercept and Acadia\, but the event also featured some innovative biotech companies from the local area Valley Fever Solutions and Prometheus Laboratories. \nFor more information visit – http://www.arena-international.com/ctssocal
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-southern-california-2017/
LOCATION:La Jolla\, San Diego (Venue TBC)
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171128
DTEND;VALUE=DATE:20171130
DTSTAMP:20260515T042510
CREATED:20171018T003307Z
LAST-MODIFIED:20171018T003542Z
UID:3481-1511827200-1511999999@www.pharmajournalist.com
SUMMARY:Ophthalmic Drugs
DESCRIPTION:SMi Group are thrilled to announce the launch of the Ophthalmic Drugs Conference\, being held on the 28-29 November 2017 at the Copthorne Tara Hotel in London\, UK. \n \nOcular disease therapy has seen a surge in innovation in areas ranging from glaucoma to macular degeneration and diabetic retinopathy. As ageing populations grow globally the need for treatment in this field has grown and is expected to reach a figure of $21 billion by the year 2022. – (Source: Business Wire –http://bit.ly/2rlECrh) \nOphthalmic Drugs will gather industry leaders to discuss the latest challenges and changes in the field of ophthalmology. Explore novel approaches to treatment\, ocular medical devices\, targeted drug delivery technology and real-life challenges to pre-clinical and clinical trials\, to deepen your understanding of inherited ocular diseases. \n‘By far the most important organs of sense are our eyes. We perceive up to 80 per cent of all impressions by means of our sight. And if other senses such as taste or smell stop working\, it’s the eyes that best protect us from danger.’ – (Source: Zeiss –http://bit.ly/2tl5iua) \nHow Will You Benefit? \nNetwork and learn from leading professionals such as: \n– Naj Sharif\, Executive Director in R&D\, Head\, Global Alliances & External Research\, Santen Inc\n– Mitchell de Long\, Vice President\, Chemistry\, Aerie Pharmaceuticals\n– Michael Lai\, Global Program Medical Director\, Novartis\n– Sérgio Leal\, Ophthalmologist Director\, Global Clinical Leader\, Bayer\n– Victor Chong\, Global Head of Ophthalmology\, Boehringer Ingelheim\n– Amir Shojaei\, Vice President Therapeutic Area Head\, Ophthalmology\, Shire\n– Tomas Navratil\, Senior Vice President\, Development\, Envisia Therapeutics \nVisit the website for the full speaker line-up: www.ophthalmicdrugs.com/pj \nSome of the featured highlights will include: \n– New approaches to drug delivery to the back of the eye and nanotechnology\n– Discover innovation in diagnostic technology\n– Regulatory keynote on medical devices and human factors\n– Explore various combination products improving health outcomes\n– Exciting insight into stem cell and gene therapy \nView the full agenda: www.ophthalmicdrugs.com/pj
URL:https://www.pharmajournalist.com/event/ophthalmic-drugs/
LOCATION:London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:psolanki@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171128
DTEND;VALUE=DATE:20171130
DTSTAMP:20260515T042510
CREATED:20170829T093920Z
LAST-MODIFIED:20170829T094210Z
UID:2969-1511827200-1511999999@www.pharmajournalist.com
SUMMARY:Pharma and Device Packaging and Labeling West Coast 2017
DESCRIPTION:Following a very successful launch year\, we are thrilled to announce that Pharma and Device Packaging and Labeling will be returning to the West Coast for our 2nd annual event. \nBringing together those involved in packaging\, labeling and supply chain in both pharmaceutical and medical device companies\, this event offers you the only chance to discuss\, deliberate and debate the pressing issues for the industry. With varied subjects covered from Core Data Sheet to UDI\, packaging innovation to artwork management and everything in between\, our 2017 show promises to bring you even more relevant and divisive content. \n\nA look back at our inaugural 2016 event… \nIn 2016 we launched our successful Pharma Packaging and Labeling USA event in San Francisco\, after many successful ongoing years in Philadelphia. Bringing together both the pharmaceutical and medical device industries in the area\, our agenda focused on the commercial packaging and labeling challenges and innovations shaking up the industry now and in the future.
URL:https://www.pharmajournalist.com/event/pharma-device-packaging-labeling-west-coast-2017/
LOCATION:Burlingame\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171116
DTEND;VALUE=DATE:20171118
DTSTAMP:20260515T042510
CREATED:20171018T002540Z
LAST-MODIFIED:20190521T093633Z
UID:3476-1510790400-1510963199@www.pharmajournalist.com
SUMMARY:Lyophilization USA
DESCRIPTION:Following its successful second year\, SMi Group announces the return of its 3rd annual Lyophilization USA Conference to New Jersey\, this November 2017. \n \nAs biopharmaceuticals continue to dominate the market\, the need for greater shelf life and protein stability\, has increased. For many biological products lyophilization is a necessity and the technology is constantly advancing. \nOne of the main challenges in pharmaceutical lyophilization\, continues to be the scale- up and the implementation of QbD protocols for the optimization of cycles. Several companies are researching and developing ways to facilitate commercial bulk lyophilization of vaccines\, protein and cells while also reducing costs. \nLyophilization USA will gather leading experts from top pharma companies to discuss the latest cutting edge developments in freeze drying\, as well as solutions to on-going industry challenges. \nKey Topics Addressed: \n– The impact of controlled nucleation on product quality and the technology being used for controlled ice         nucleation.\n– Examining the development and scale up of a freeze-drying cycle for biotherapeutics.\n– Highlighting the approaches to effective holistic packaging and innovative design. \nFeatured Speakers: \n– Lokesh Kumar\, Associated Scientist\, Genentech\n– Charlie Tang\, Associate Director\, Formulation Development\, Regeneron Pharmaceuticals\n– Guido Schmitz\, Global Head of Packaging & Technology Innovation\, Bayer Consumer Care\n– Perceval Sondag\, Principal Statistician\, Arlenda\n– Eric Munson\, Professor\, Pharmaceutical Sciences\, University of Kentucky\n– Kelly Forney Stevens\, Drug Product Development\, GSK Vaccines\n– Melissa Lash\, Scientist\, Large Molecule Drug Development\, Johnson & Johnson \nView the preliminary agenda here: www.lyophilization-usa.com/pj
URL:https://www.pharmajournalist.com/event/lyophilization-usa/
LOCATION:Iselin\, New Jersey
ORGANIZER;CN="SMi Group Ltd":MAILTO:events@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171115
DTEND;VALUE=DATE:20171117
DTSTAMP:20260515T042510
CREATED:20170628T035014Z
LAST-MODIFIED:20170628T035419Z
UID:2414-1510704000-1510876799@www.pharmajournalist.com
SUMMARY:4th annual Biosimilars North America
DESCRIPTION:Building on the success of previous events\, SMi has announced the return of its 4th annual Biosimilars North America Conference\, taking place on November 15 and 16\, 2017 in Iselin\, New Jersey. \nThe market for biosimilars in North America continues to grow and has become highly lucrative. As such\, pharmaceutical companies continue to find ways to differentiate their products in such an emerging market. Thus\, Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development\, and ensure optimal market access and commercialization opportunities whilst complying with evolving regulatory requirements. \nThis year\, the conference will also explore significant developmental topics within the sector including the impact of FDA’s newly implemented biosimilar interchangeability guidelines\, the US market access landscape\, and biosimilars of orphan drugs. \nKey highlights this year will include \n\na presentation from Sandoz on the FDA issuing the long-awaited biosimilar interchangeability guidance;\na session on complex biosimilars and new technologies from MedImmune;\nstrategies to combat legal\, policy and commercial obstacles to development and launch;\ninsights on latest development strategies and market access from Fujifilm Diosynth Biotechnologies;\ncase studies on drug product and formulation development considerations; and\nImplications of the landmark ruling of the Amgen v Sandoz case\n\nKey speakers include \n\nRichard DiCicco\, Chairman\, Harvest Moon Pharmaceuticals Inc\nCindy Cao\, Executive Director & Head of US Regulatory Affairs fo Biopharmaceuticals\, Sandoz\nT. Shantha Raju\, Senior Director\, MedImmune\nChrys Kokino\, Head Global Biologics Commercial\, Mylan\nSteinar Madsen\, Medical Director\, Norwegian Medicines Agency\nBruce Leicher\, Senior Vice President and General Counsel\, Momenta Pharmaceuticals\, Inc\nHiten Gutka\, Principal Scientist Formulation Development – Biosimilar Development\, Oncobiologics Inc\nPatrick Robertson\, Director\, Program Design\, FUJIFIlM Diosynth Biotechnologies\n\nThe full roster of speakers and their topics can be found on www.biosimilars-northamerica.com/pharmajournalist \nRegistration is now live on the event website and there For more information visit: www.biosimilars-northamerica.com/pharmajournalist
URL:https://www.pharmajournalist.com/event/4th-annual-biosimilars-north-america/
LOCATION:Renaissance Woodbridge Hotel\, Iselin\, New Jersey\, USA
ORGANIZER;CN="SMi Group Ltd":MAILTO:events@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171102
DTEND;VALUE=DATE:20171104
DTSTAMP:20260515T042510
CREATED:20170810T054305Z
LAST-MODIFIED:20170810T054554Z
UID:2829-1509580800-1509753599@www.pharmajournalist.com
SUMMARY:APPCON India - ASIAN Pharma Packaging Conference
DESCRIPTION:The objective of the conference is to secure and optimize packaging by navigating regulatory requirements with innovative materials and technologies. \nKey Highlights: \n\n20+ speakers\n100+ senior packaging heads from pharma companies\n10 exhibitors\n2-days of branding opportunities through innovative formats such as technology shootout\, site visit and speaking\n\nEarly Confirmed Speakers: \n\nChief Advisor: Santanu Chowdhury\, Senior General Manager\, Packaging Development\, Sun Pharma\nBarun Kumar Dey\, Director & Head Packaging Development\, Dr Reddy’s Laboratories\nLokesh Sharma\, Director-Supply Chain\, Eisai Pharmaceuticals\nPrasad Satam\, GM Packaging Research Development\, Aurobindo Pharma\nAlpesh Shah\, General Manager-Packaging\, Intas Pharmaceuticals\nKaushik Roy\, GM – Packaging Research Development\, Mylan Laboratories\nPradeep Dhargalkar\, Head Packaging Development\, Unichem Laboratories\nAtul Mulay\, Deputy General Manager – Packaging Development\, Cadila Pharmaceuticals\nAjay Bapat\, Head Packaging Development\, Emcure Pharmaceuticals\nMunindra Roy\, Senior Manager Packaging Development\, Gland Pharma\nK Ram Mohan\, Senior Packaging\, NATCO Pharma\nRohan Aranha\, Head of Packaging R&D\, IPCA Laboratories\nSaravanan TJ\, Associate Director Quality Assurance Packaging\, Biocon\nBharat Pawar\, Drug Delivery Device And Pkg. Development\, SERUM INSTITUTE\nLalan Yadav\, Senior Manager – Asia Head\, Abbott\nSenior Representative\, Indian Institute of Packaging\, (IIP)\nBimal Mehta\, Managing Director\, Vakils Premedia\nMark Ennis\, Global Business Development Director\, Perigord\n\nTo request the Latest Agenda & more details on the Programme\, Speakers and their Presentations by email\, please contact Priyesh Waghmare \nSpecialist Content:  \n\nRegulatory Compliance Packaging\nSerialization\nTamper-Proof Packaging\nAnti-Counterfeiting Solutions\nPatient Friendly Packaging\nInnovative Materials\, Machinery and Technology\nCold Chain Packaging\nAutomation Packaging\n\nWe are now open for number of speaking\, sponsorship\, exhibiting and advertisement opportunities available for companies who wish to communicate their product and service offering to above elite group. We have some special and attractive sponsorship packages made exclusively for you. \nKey advantages of partnering with us: \n\nPositionyourself as a thought leader in the industry\nDelivera product presentation in the networking area\nShowcaseyour products and services in the exhibition area\nAdvertiseyour solutions in the on-site delegate booklet\nDistributeyour literature to all the attendees\nBrandyour company on our conference materials\n\nPrevious Singapore Edition Attendees Included: \nAbbott Manufacturing Singapore\, Amcor\, Apex Pharma Marketing Pte Ltd\, ARQon Pte Ltd\, Astellas Pharma Singapore Pte. Ltd\,Avery Dennison Singapore (Pte) Ltd\, Beacons Pharmaceuticals Pte Ltd\, Constantia Flexibles International GmbH\, Dätwyler Sealing Solutions\, DKSH Singapore Pte Ltd\, Dnahc Cambodia\, Dr Reddy’s Laboratories\, Ekberg Emballage AB\, Esko Graphics\, European Chamber of Commerce (Singapore)\, General Mills\, GlaxoSmithKline Consumer Healthcare\, Goldplus Universal Pte Ltd\,HGP Asia Pte\, ICM Pharma Pte. Ltd.\, Agency for Science Technology and Research (A*STAR)\, Klöckner Pentaplast\, LF Asia Distribution\, Medicell Pharmaceutical (S) Pte. Ltd\, Mundipharma\, MVK Meditech\, National Environment Agency\, Nicosia Creative Espresso Pte Ltd\, Opto-Pharm Pte Ltd\, Orient Design\, Parexel International Pvt Ltd\, Pharma Pharmaceutical Industries\, PT Bayer Indonesia\, PT Graha Farma\,PT Kalbe Farma\, PT Kino Indonesia\, PT. Galenium Pharmasia Laboratories\, RVK Meditech\, Sanofi\, SICPA\, SPA Governing Board\, Sun Pharma\, Tesa Scribos GmbH\, Teva Pharmaceutical\, ThePackHub\, Uhlmann Singapore LLP\,UPM Raflatac\, Versalis Spa\, BOBST\, Softbox Systems\, SHL Group and many more… \nEvent Website: http://www.wplgroup.com/aci/event/pharma-packaging-india/ \nQuote discount code: \nPPCi1MP20 to claim for 20% discount expiring 7th September 2017 & \nPPCi1MP15 to claim for 15% discount expiring 19th October 2017
URL:https://www.pharmajournalist.com/event/appcon-india-asian-pharma-packaging-conference/
LOCATION:Mumbai-India
ORGANIZER;CN="Active Communications International (ACI)":MAILTO:pwaghmare@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171018
DTEND;VALUE=DATE:20171020
DTSTAMP:20260515T042510
CREATED:20170810T055616Z
LAST-MODIFIED:20170810T055704Z
UID:2836-1508284800-1508457599@www.pharmajournalist.com
SUMMARY:Big Data & Analytics for Pharma Summit
DESCRIPTION:The Big Data & Analytics for Pharma Summit returns to San Francisco this October 18-19 in what promises to be another must attend event. Join over 80 big data and analytics professionals within the the pharmaceutical industry as you enjoy two days of inspiring\, educational & informative presentations\, panel sessions & networking opportunities. Learn from leading experts on how you can leverage data analytics to deliver patient-centric outcomes. Sign up today or download free brochure! \nFor more information\, please visit: https://goo.gl/sTpNCq
URL:https://www.pharmajournalist.com/event/big-data-analytics-pharma-summit/
LOCATION:Parc 55 San Francisco
ORGANIZER;CN="Innovation Enterprise":MAILTO:jc@theiegroup.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171018
DTEND;VALUE=DATE:20171020
DTSTAMP:20260515T042510
CREATED:20170718T040953Z
LAST-MODIFIED:20170718T041135Z
UID:2512-1508284800-1508457599@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply East Coast 2017
DESCRIPTION:The 15th Annual CTS East Coast event builds on last year’s conference\, Arena’s biggest East Coast CTS event to date. To do this we have added a one day stream covering the emergence and adoption of innovative technology to find solutions for your clinical trial supply problems\, whilst also offering a larger variety of sessions covering all the essentials in clinical supply\, from maximising forecasting software to managing a yo-yoing workforce and uncovering what is driving supply outsourcing. \nFor more information visit – http://www.arena-international.com/ctseastcoast
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-east-coast-2017/
LOCATION:Princeton\, New Jersey (Venue TBC)
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171002
DTEND;VALUE=DATE:20171114
DTSTAMP:20260515T042510
CREATED:20170817T065631Z
LAST-MODIFIED:20170817T082858Z
UID:2901-1506902400-1510617599@www.pharmajournalist.com
SUMMARY:Introduction to HPLC\, HPLC Troubleshooting and Method Development Online Academy
DESCRIPTION:Pharmaceutical Training International (PTI) introduces our HPLC Online Academy. \nIntroduction to HPLC\, HPLC Troubleshooting and Method Development – Online Academy\n6 week online course\, starting 2nd October\, 2017: 1.5 hours per week \nGain a complete guide to HPLC\, troubleshooting and method development from our industry expert\, Dr Mark Powell. \nAvoid the many challenges that HPLC presents\, from basic underlying concepts\, to troubleshooting problems\, to optimising the resolution. \nThe flexible learning means you have a choice of taking 3 topics\, each containing 3 hour-long modules. You may choose any one\, two\, or all three\, depending on how advanced or basic your understanding of HPLC. \n– Topic 1: Introduction to HPLC\, released on 2nd October\, 2017\n– Topic 2: HPLC Troubleshooting\, released on 16th October\, 2017\n– Topic 3: HPLC Method Development\, released on 6th November\, 2017 \nTo find out more about this course\, please visit the course website or view the full agenda here. \nThe Online Academy is a new digital\, interactive and engaging education tool designed to maximise learning for professionals with busy schedules and/or small training budgets. \nTo find out more about our online academies\, please visit our website \nAbout PTI \nPTI is a global interactive training partner committed to the personal progression of aspiring life science professionals. We have a network of expert trainers who have a minimum of 10 years’ industry experience to meet your training requirements and all our courses are CPD certified.
URL:https://www.pharmajournalist.com/event/introduction-hplc-hplc-troubleshooting-method-development-online-academy/
LOCATION:Online Course
ORGANIZER;CN="PTI Global":MAILTO:Nabihah.Durrani@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170926
DTEND;VALUE=DATE:20170928
DTSTAMP:20260515T042510
CREATED:20170817T001521Z
LAST-MODIFIED:20170817T002251Z
UID:2889-1506384000-1506556799@www.pharmajournalist.com
SUMMARY:BioPharm America™ 2017
DESCRIPTION:BioPharm America™ 2017—10th Annual International Partnering Conference\nAccess capital\, innovation and partners \nBioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Now in its tenth year\, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms\, major pharmaceutical companies\, academic institutions and biotechnology companies of every size and stage\, from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. \n \nA primary focus of BioPharm America™ is the one-to-one meetings driven by partneringONE®\, the industry’s most robust software platform. Delegates can request and schedule meetings tailored to their strategic business goals to create a dynamic personalized agenda that includes regular alerts for further meeting opportunities. \nThe impetus behind this intensive business development activity is a two-day \nconference program that features thought leaders and executives from across the life science industry. To help bring attention to early stage projects and small entrepreneurial companies\, BioPharm America features special tracks specifically designed for startups and young companies to get on the radar of the global life science community and to make the connections that matter. Engaging panel discussions cover topics of interest to dealmakers including licensing\, investment and business development. \nLeading pharmaceutical companies attend BioPharm America in search of innovation\, such as Amgen\, AstraZeneca\, Bayer HealthCare\, Biogen Idec\, Boehringer Ingelheim\, Genentech\, Sanofi/Genzyme\, Gilead\, Ironwood\, Johnson & Johnson Innovation\, Merck\, Novo Nordisk\, Nycomed\, Pfizer\, and Shire. Held in Boston each September\, the event attracted 850+ delegates from 525 companies who participated in 2\,350+ scheduled one-to-one meetings in 2016. \nTo learn more about this event\, and to register online\, visit https://goo.gl/SZfnmi \nProducer: \nEBD Group\, Inc.\nEBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions\, conferences and training in the world.  \nContact: \nCassidy Hamilton\nEBD Group\nCarlsbad\, CA\n+1 760 930 0500\nchamilton@ebdgroup.com \n 
URL:https://www.pharmajournalist.com/event/biopharm-america-2017/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="EBD Group%2C Inc.":MAILTO:chamilton@ebdgroup.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170925
DTEND;VALUE=DATE:20170930
DTSTAMP:20260515T042510
CREATED:20170626T071104Z
LAST-MODIFIED:20170627T074854Z
UID:2392-1506297600-1506729599@www.pharmajournalist.com
SUMMARY:15th Annual Global Forum
DESCRIPTION:Returning for its 15th iteration\, the world’s largest event for temperature-controlled life science supply chains heads back to Chicago this year with a focus on the next generation of temperature control! Join 850+ attendees from 30+ countries for five days of master classes\, workshops\, track sessions\, panel discussions\, roundtables\, and more.  With the Global Forum\, your company will meet emerging and ongoing challenges for 2017 and beyond. \nTo learn more about this event visit http://bit.ly/2tKDbVk \nDownload the Event Agenda: http://bit.ly/2taKpon \nTo register please visit http://bit.ly/2sQSeN9
URL:https://www.pharmajournalist.com/event/15th-annual-global-forum/
LOCATION:Hyatt Regency McCormick Place\, Chicago\, IL
ORGANIZER;CN="IQPC North America":MAILTO:enquiry@iqpc.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170925
DTEND;VALUE=DATE:20170928
DTSTAMP:20260515T042510
CREATED:20170620T091806Z
LAST-MODIFIED:20170620T092213Z
UID:2329-1506297600-1506556799@www.pharmajournalist.com
SUMMARY:FierceBiotech 2nd Drug Development Forum
DESCRIPTION:The 2nd annual FierceBiotech Drug Development Forum will draw together the industry’s executive decision-makers\, to help guide your companies to success throughout the entire life cycle – both for products and for companies themselves. This event gives biopharma leaders the skills to improve their partnership strategies with larger companies\, financing sources and outsourced research partners. Our experienced and savvy executive-level speaking faculty will help you shape\, select and pitch the best partnerships for drug development\, while successfully navigating the financial and regulatory changes arising from a new administration. Target your learning opportunities toward four full-length tracks: Strategic Deal-Making\, Clinical Research Outsourcing & Technology\, Improving R&D Outcomes and Digital Technology & Real-World Evidence. We invite you to join this unparalleled opportunity to work with your peers toward a quantum leap in drug development productivity and speed! \nTo learn more about this event\, and to register online\, visit http://bit.ly/2sOSHSE
URL:https://www.pharmajournalist.com/event/fiercebiotech-2nd-drug-development-forum/
LOCATION:Renaissance Boston Waterfront Hotel\, 606 Congress Street\, Boston\, MA 02210
ORGANIZER;CN="ExL Events":MAILTO:amagnolo@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170912
DTEND;VALUE=DATE:20170914
DTSTAMP:20260515T042510
CREATED:20170718T040342Z
LAST-MODIFIED:20170718T040609Z
UID:2505-1505174400-1505347199@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Midwest 2017
DESCRIPTION: This unique event brings together leading pharma\, device and biotech professionals from across the Midwest region. After a hugely successful launch event in 2016\, the Clinical Trials Supply Midwest Conference will be returning to Chicago for its 2nd edition\, with more content and senior level speakers than before. The Clinical Trial Supply stream will also now be run across the full 2 days due to increased demand.
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-midwest-2017/
LOCATION:Chicago\, Illinois (Venue TBC)
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170907
DTEND;VALUE=DATE:20170909
DTSTAMP:20260515T042511
CREATED:20170619T035153Z
LAST-MODIFIED:20170619T035851Z
UID:2282-1504742400-1504915199@www.pharmajournalist.com
SUMMARY:Life Science Investor Relations Forum
DESCRIPTION:Exl’s Life Science IR Forum\, taking place on September 7-8\, 2017 at the Revere Hotel in Boston\, MA\, will bring together IR professionals to address the diverse set of challenges faced in the life sciences industry. Our expert speaking faculty will provide thought-provoking dialogue paired with networking opportunities that no other conferences address. IR teams are continuously balancing new regulations\, advancements in technology\, more engaged investors and working relationships with advisory boards. Through this event\, IR specialists will be able to efficiently gain the knowledge they need to improve their programs while developing a new network of educated IR colleagues. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2rMkxvl
URL:https://www.pharmajournalist.com/event/life-science-investor-relations-forum/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA 02116
ORGANIZER;CN="ExL Events":MAILTO:cbrady@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170906
DTEND;VALUE=DATE:20170908
DTSTAMP:20260515T042511
CREATED:20170623T033647Z
LAST-MODIFIED:20170623T033647Z
UID:2374-1504656000-1504828799@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials New England
DESCRIPTION:OCT New England returns to Boston this September with an agenda that hosts new session formats including an ideal pool\, lightning round and workshops. Last year the event saw countless attendees engage in thought leadership presentations and interactive discussions which enabled relationship building and the creation of long lasting relationships. The agenda will address many key themes such as managing vendor contracts and overcoming the challenges of using mobile devices in trials.  \nWe invite you to join us for an event that is promised to be bigger and better than ever. Simply visit the website today to register online http://www.arena-international.com/octnewengland/  
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-new-england/
LOCATION:Boston\, MA
ORGANIZER;CN="Arena International":MAILTO:sarah.rosenberg@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170906
DTEND;VALUE=DATE:20170908
DTSTAMP:20260515T042511
CREATED:20170502T034747Z
LAST-MODIFIED:20170502T040051Z
UID:1574-1504656000-1504828799@www.pharmajournalist.com
SUMMARY:2nd European Prefilled Syringes Summit
DESCRIPTION:After the success of our first European Prefilled Syringes Summit\, we are pleased to announce the next edition which shall take place on the 6th & 7th September in Berlin\, Germany. \n \nACI’s European Prefilled Syringes Summit will explore the advancements in regulatory guidelines\, product development\, manufacturing processes\, risk mitigation \, portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology\, connectivity\, speed to market\, and next generation syringes. There are several elements that pose a severe challenge to the growth of the global prefilled syringes market\, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs. Other more traditional factors inhibiting the market include product recalls due to breakages and leachables\, the potential risk of interaction between prefilled syringes and drugs\, and needle stick prevention. \nKey Topics Include:  \n\nEuropean prefilled syringes market & growth opportunities\nTrends in modern biologics targeting therapeutic classes of drugs that are considered to be the primary growth drivers within the market\nLatest FDA guidelines in receiving PFS & overcoming complex requirements for approval\nSpecialty syringes\, which include prefilled flush syringes\, prefilled diluent systems and contrast agents in prefilled syringe\nConcentrating on Next Generation Smart Devices while Overcoming Traditional Challenges\nManaging the Materials used to Construct Pre-Filled Syringes—Selection and Supply Chain Control\nBalancing biopharmaceutical product portfolio for continual product innovation\, such as incorporating a new delivery component and Creating a lower-risk product development strategy\nUsability: Key Human Factor Attributes & Interactive Considerations.\nThe Drug/Device interface: Integration of the formulation and the device \n\n15% subscriber’s discount available on the registration fee.  \nTo receive the agenda or for the priority registration\, please contact\nMohammad Ahsan on +44 (0)20 3141 0606 or email: mahsan@acieu.net \nConference Fee:               £1\,595 (£240 Discount for all members/subscribers) \nDownload the Brochure : http://www.wplgroup.com/aci/wp-content/uploads/sites/2/2017/03/PPFE2-Agenda_MKT.pdf \nDownload the Brochure Now!
URL:https://www.pharmajournalist.com/event/2nd-european-prefilled-syringes-summit/
LOCATION:Berlin\, Germany\, India
ORGANIZER;CN="Active Communications Europe Ltd (ACI)":MAILTO:mahsan@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170828
DTEND;VALUE=DATE:20170830
DTSTAMP:20260515T042511
CREATED:20170515T091448Z
LAST-MODIFIED:20170515T091721Z
UID:1818-1503878400-1504051199@www.pharmajournalist.com
SUMMARY:7th American Drug Delivery & Formulation Summit
DESCRIPTION:Innovative solutions to the greatest challenges in pharmaceutical development \n\n\nThe growth of biopharma and patient compliance issues have encouraged us to adopt a drug delivery mind set from discovery through to production.Every year we see innovation and breakthroughs at every level of drug development. \nThe DDF Summit brings the most innovative and exciting studies to you. \nCovering both small molecules and biologics\, you’ll find new technologies\, concepts and case studies in areas such as… \n\nFormulation design for poorly soluble compounds\nThe potential of nanotechnology for better deliverability\nThe latest controlled released technologies\nImproving patient compliance by harnessing data and the latest smart device technology\nOptimising formulations for continuous manufacturing\nOvercoming the blood brain barrier and challenges in oral delivery of biologics\nReformulation and biosimilars
URL:https://www.pharmajournalist.com/event/7th-american-drug-delivery-formulation-summit/
LOCATION:The Westin Copley Place Boston Hotel
ORGANIZER;CN="Mark Allen Group":MAILTO:mabconferences@markallengroup.com 
END:VEVENT
END:VCALENDAR